Indeed, serum concentrations of IL-1β were found to be elevated in obese individuals, and correlated with insulitis and diabetes [19], while neutralization of IL-1β action via IL-1 receptor antagonist improves metabolic parameters in type 2 diabetes [49]. Here, IL1B is linked to type 2 diabetes mellitus.